viewA-Cap Resources Ltd

A-Cap Resources completes first leg of $5.8 million capital raising


A-Cap Resources (ASX: ACB) has raised $1.32 million through a placement to institutional investors based in the United Kingdom as part of a broader $5.8 million capital raising.

Funds from the placement will enable critical path drilling, process design and environmental work at its Letlhakane Uranium Project in Botswana to commence immediately.

Letlhakane ranks as one of the largest under-developed uranium deposits in the world with a resource of 308 million pounds of U3O8 along with separate strata that contain 107.3 million tonnes of thermal coal.

The remaining $4.48 million will be raised through a fully underwritten 1 for 3.5 non-renounceable, entitlement offer of 81,824,282 new shares priced at $0.055 per share.

Ansheng Investment Company Ltd, an entity which is controlled by Angang Shen, a director of the A-Cap, will underwrite this offer.

Funds will also be used to advance the Company’s coal projects following positive reports received from independent consultants on the development potential of these assets.

Letlhakane Uranium Project

Letlhakane is one of few global uranium projects capable of commencing production within the next three years.

In February of 2013 the company completed an internal Scoping Study that evaluated a shallow open pit mining operation of less than 75 metres in depth, and heap leach process route to produce 3 million pounds of uranium per year over a mine life that exceeds 25 years.

Power, road, rail and water infrastructure is readily available while the project’s soft near-surface ore requires just low-cost mining and heap leach acid processing.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: A-Cap Resources Ltd

Price: 0.007 AUD

Market: ASX
Market Cap: $6.1 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



OptiBiotix Health CEO updates on new deal with Actial Farmaceutica and...

OptiBiotix Health's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott following the news they've signed a distribution deal covering Australia, New Zealand, Indonesia, and Thailand for its cholesterol and blood pressure reducing dietary supplements, CholBiome and CholBiome...

15 hours, 1 minute ago

2 min read